Budget Impact Analysis of Ceftaroline Versus Linezolid or Vancomycin on the Top of Standard Therapy in the Treatment of Complicated Skin and Soft Tissues Infections in Russian Federation
Nov 1, 2013, 00:00
10.1016/j.jval.2013.08.134
https://www.valueinhealthjournal.com/article/S1098-3015(13)02039-1/fulltext
Title :
Budget Impact Analysis of Ceftaroline Versus Linezolid or Vancomycin on the Top of Standard Therapy in the Treatment of Complicated Skin and Soft Tissues Infections in Russian Federation
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(13)02039-1&doi=10.1016/j.jval.2013.08.134
First page :
A345
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
125